pubrio
Exelixis logo

Exelixis

Public
exelixis.com
生物技術研究1,500+ employeesFounded 1994🇺🇸 美國

Every Exelixis employee is united in an ambitious cause: to transform science into new treatments that give cancer patients and their families hope for the future. In this pursuit, we know our employees are our most valuable asset. As a diverse, growing team, everyone at Exelixis plays a role in advancing our mission through our innovative drug discovery, development and commercialization efforts. We take pride in our shared purpose, knowing the magnitude of our impact expands with every medicine we create and every form of cancer tumor type we treat. After operating in the challenging biotech sector for nearly three decades, we've evolved into a multi-platform cancer company with a proven track record of resiliency in the face of adversity. The success of our flagship commercial product set us up on our journey to discover and develop next-generation cancer treatments, driven by our relentless pursuit of results for the patients we serve. Cancer is our cause. Make it yours, too. Please see our Community Guidelines: bit.ly/4iBzJU0 For more information about Exelixis, please visit www.exelixis.com, follow @ExelixisInc on Twitter or like Exelixis, Inc. on Facebook.

成立年份
1994
員工
1,500+
行業
生物技術研究
公司類型
Public Company
股票
nasdaq: EXEL
總部
🇺🇸Alameda, California
專長
研究產業製藥產業生物技術醫療保健生物技術研究
1 / 1
活躍市場
1
新市場
IN
信心度
大多為早期訊號
-100%
動能
對比上一週期
31 / 100
擴張評分
發展中
階段1投入中
1 個訊號 · 過去 90 日

全球擴張

即時
IN
階段
探索中投入中進入中營運中

活動脈搏

過去 90 日內有 1 個訊號。

過去 90 日
招聘
1已結束
高層異動
市場推廣與公關
0
無活動
產品與技術
0
無活動
+2個類別已鎖定
已顯示 5 個中的 3 個

市場進入時間軸

此公司進入各市場的次序 — 由最舊至最新

1
🇮🇳IN第 1st 個進入的市場 · 2026推進中
投入中
1 個訊號投入中 階段
目前階段投入中投入資源
信心度25%
開始追蹤於2026首個訊號

近期訊號

高層異動🇮🇳 IN2個月前

Director

註冊以查看完整訊號動態

值得了解

關於 Exelixis 的常見問題

關於 Exelixis 業務、市場及增長訊號的快速解答。

Every Exelixis employee is united in an ambitious cause: to transform science into new treatments that give cancer patients and their families hope for the future. In this pursuit, we know our employees are our most valuable asset. As a diverse, growing team, everyone at Exelixis plays a role in advancing our mission through our innovative drug discovery, development and commercialization efforts. We take pride in our shared purpose, knowing the magnitude of our impact expands with every medicine we create and every form of cancer tumor type we treat. After operating in the challenging biotech sector for nearly three decades, we've evolved into a multi-platform cancer company with a proven track record of resiliency in the face of adversity. The success of our flagship commercial product set us up on our journey to discover and develop next-generation cancer treatments, driven by our relentless pursuit of results for the patients we serve. Cancer is our cause. Make it yours, too. Please see our Community Guidelines: bit.ly/4iBzJU0 For more information about Exelixis, please visit www.exelixis.com, follow @ExelixisInc on Twitter or like Exelixis, Inc. on Facebook.

立即展開你的旅程

可以先用平台,也可以先聊聊

自行使用 Pubrio,或讓我們的團隊協助研究、挖掘潛在客戶,甚至串接資料。

Start Journey Image
pubrio

Pubrio 將 50+ 個在地來源的商業、人才與意圖數據全球化整合,讓 AI 與營收團隊掌握完整市場視野。

© 2026 Pubrio。版權所有。